{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:36:45Z","timestamp":1769150205149,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"crossref","award":["#19K16962"],"award-info":[{"award-number":["#19K16962"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s12185-023-03659-y","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T14:02:34Z","timestamp":1695736954000},"page":"577-588","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comprehensive comparison of global coagulation assays to differentiate lupus anticoagulant from acquired hemophilia A in patients with prolonged APTT"],"prefix":"10.1007","volume":"118","author":[{"given":"Yushi","family":"Chikasawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kagehiro","family":"Amano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Shinozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Bingo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryui","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayano","family":"Mitsuhashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ei","family":"Kinai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"key":"3659_CR1","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","volume":"18","author":"KMJ Devreese","year":"2020","unstructured":"Devreese KMJ, de Groot PG, de Laat B, Erkan D, Favaloro EJ, Mackie I, et al. Guidance from the scientific and standardization committee for lupus anticoagulant\/antiphospholipid antibodies of the international society on thrombosis and haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation. J Thromb Haemost. 2020;18:2828\u201339.","journal-title":"J Thromb Haemost"},{"key":"3659_CR2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/labmed\/lmx050","volume":"48","author":"WE Winter","year":"2017","unstructured":"Winter WE, Flax SD, Harris NS. Coagulation testing in the core laboratory. Lab Med. 2017;48:295\u2013313.","journal-title":"Lab Med"},{"key":"3659_CR3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.thromres.2016.05.004","volume":"143","author":"O Kumano","year":"2016","unstructured":"Kumano O, Ieko M, Naito S, Yoshida M, Takahashi N, Suzuki T, et al. New formulas for mixing test to discriminate between lupus anticoagulant and acquired hemophilia A. Thromb Res. 2016;143:53\u20137.","journal-title":"Thromb Res"},{"key":"3659_CR4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0039-1678719","volume":"45","author":"EJ Favaloro","year":"2019","unstructured":"Favaloro EJ, Kershaw G, Mohammed S, Lippi G. How to optimize activated partial thromboplastin time (APTT) testing: solutions to establishing and verifying normal reference intervals and assessing APTT reagents for sensitivity to heparin, lupus anticoagulant, and clotting factors. Semin Thromb Hemost. 2019;45:22\u201335.","journal-title":"Semin Thromb Hemost"},{"key":"3659_CR5","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1055\/s-0038-1651083","volume":"57","author":"E Rosner","year":"1987","unstructured":"Rosner E, Pauzner R, Lusky A, Modan M, Many A. Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost. 1987;57:144\u20137.","journal-title":"Thromb Haemost"},{"key":"3659_CR6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1055\/s-0037-1615621","volume":"85","author":"GC White II","year":"2001","unstructured":"White GC II, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the international society on thrombosis and haemostasis. Thromb Haemost. 2001;85:560.","journal-title":"Thromb Haemost"},{"key":"3659_CR7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/ijlh.12227","volume":"36","author":"GW Moore","year":"2014","unstructured":"Moore GW. Commonalities and contrasts in recent guidelines for lupus anticoagulant detection. Int J Lab Hematol. 2014;36:364\u201373.","journal-title":"Int J Lab Hematol"},{"key":"3659_CR8","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1111\/j.1538-7836.2009.03555.x","volume":"7","author":"V Pengo","year":"2009","unstructured":"Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on lupus anticoagulant\/antiphospholipid antibody of the scientific and standardisation committee of the international society on thrombosis and haemostasis. J Thromb Haemost. 2009;7:1737\u201340.","journal-title":"J Thromb Haemost"},{"key":"3659_CR9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1365-2141.2012.09037.x","volume":"157","author":"D Keeling","year":"2012","unstructured":"Keeling D, Mackie I, Moore GW, Greer IA, Greaves M. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol. 2012;157:47\u201358.","journal-title":"Br J Haematol"},{"key":"3659_CR10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/rth2.12245","volume":"3","author":"O Kumano","year":"2019","unstructured":"Kumano O, Moore GW. Ruling out lupus anticoagulants with mixing test-specific cutoff assessment and the index of circulating anticoagulant. Res Pract Thromb Haemost. 2019;3:695\u2013703.","journal-title":"Res Pract Thromb Haemost"},{"key":"3659_CR11","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3324\/haematol.2008.001743","volume":"94","author":"A Huth-K\u00fchne","year":"2009","unstructured":"Huth-K\u00fchne A, Baudo F, Collins P, Ingerslev J, Kessler CM, L\u00e9vesque H, et al. International recommendations on the diagnosis and treatment of patients with acquired hemophilia A. Haematologica. 2009;94:566\u201375.","journal-title":"Haematologica"},{"key":"3659_CR12","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/bjh.12463","volume":"162","author":"P Wc","year":"2013","unstructured":"Wc P, Chalmers E, Hart D, Jennings I, Liesner R, Rangarajan S, et al. Diagnosis and management of acquired coagulation inhibitors: a guideline from UKHCDO. Br J Haematol. 2013;162:758\u201373.","journal-title":"Br J Haematol"},{"key":"3659_CR13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.4097\/kja.19169","volume":"72","author":"K G\u00f6rlinger","year":"2019","unstructured":"G\u00f6rlinger K, P\u00e9rez-Ferrer A, Dirkmann D, Saner F, Maegele M, Calatayud \u00c1AP, et al. The role of evidence-based algorithms for rotational thromboelastometry-guided bleeding management. Korean J Anesthesiol. 2019;72:297\u2013322.","journal-title":"Korean J Anesthesiol"},{"key":"3659_CR14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ajh.23599","volume":"89","author":"D Whiting","year":"2014","unstructured":"Whiting D, DiNardo JA. TEG and ROTEM: technology and clinical applications. Am J Hematol. 2014;89:228\u201332.","journal-title":"Am J Hematol"},{"key":"3659_CR15","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3390\/jcm11051407","volume":"11","author":"V Pavoni","year":"2022","unstructured":"Pavoni V, Gianesello L, Conti D, Ballo P, Dattolo P, Prisco D, et al. \u201cIn less than no time\u201d: feasibility of rotational thromboelastometry to detect anticoagulant drugs activity and to guide reversal therapy. J Clin Med. 2022;11:1407.","journal-title":"J Clin Med"},{"key":"3659_CR16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1159\/000071636","volume":"33","author":"HC Hemker","year":"2003","unstructured":"Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb. 2003;33:4\u201315.","journal-title":"Pathophysiol Haemost Thromb"},{"key":"3659_CR17","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1111\/jth.15529","volume":"19","author":"F Depasse","year":"2021","unstructured":"Depasse F, Binder NB, Mueller J, Wissel T, Schwers S, Germer M, et al. Thrombin generation assays are versatile tools in blood coagulation analysis: a review of technical features, and applications from research to laboratory routine. J Thromb Haemost. 2021;19:2907\u201317.","journal-title":"J Thromb Haemost"},{"key":"3659_CR18","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1373\/clinchem.2015.248625","volume":"62","author":"A Tripodi","year":"2016","unstructured":"Tripodi A. Thrombin generation assay and its application in the clinical laboratory. Clin Chem. 2016;62:699\u2013707.","journal-title":"Clin Chem"},{"key":"3659_CR19","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1111\/jth.14022","volume":"16","author":"K Nogami","year":"2018","unstructured":"Nogami K, Matsumoto T, Tabuchi Y, Soeda T, Arai N, Kitazawa T, et al. Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa\/factor X bispecific antibody emicizumab. J Thromb Haemost. 2018;16:1078\u201388.","journal-title":"J Thromb Haemost"},{"key":"3659_CR20","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1756706","author":"K Nogami","year":"2022","unstructured":"Nogami K. Clot waveform analysis for monitoring hemostasis. Semin Thromb Hemost. 2022. https:\/\/doi.org\/10.1055\/s-0042-1756706.","journal-title":"Semin Thromb Hemost"},{"key":"3659_CR21","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","volume":"5","author":"NT Connell","year":"2021","unstructured":"Connell NT, Flood VH, Brignardello-Petersen R, Abdul-Kadir R, Arapshian A, Couper S, et al. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease. Blood Adv. 2021;5:301\u201325.","journal-title":"Blood Adv"},{"key":"3659_CR22","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3324\/haematol.2019.230771","volume":"105","author":"A Tiede","year":"2020","unstructured":"Tiede A, Collins P, Knoebl P, Teitel J, Kessler C, Shima M, et al. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica. 2020;105:1791\u2013801.","journal-title":"Haematologica"},{"key":"3659_CR23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12185-021-03212-9","volume":"115","author":"M Ieko","year":"2022","unstructured":"Ieko M, Ohmura K, Naito S, Yoshida M, Saito M, Kiyohara K, et al. Measurement of coagulation factor antibody levels is useful for diagnosis and determining therapeutic efficacy in hemorrhagic patients with autoantibodies to coagulation factor VIII and factor V: results from a single center in Japan. Int J Hematol. 2022;115:11\u201320.","journal-title":"Int J Hematol"},{"key":"3659_CR24","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1160\/TH14-12-1062","volume":"114","author":"P Batty","year":"2015","unstructured":"Batty P, Moore GW, Platton S, Maloney JC, Palmer B, Bowles L, et al. Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A. Thromb Haemost. 2015;114:804\u201311.","journal-title":"Thromb Haemost"},{"key":"3659_CR25","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1182\/blood-2014-09-598268","volume":"125","author":"CJ Hofbauer","year":"2015","unstructured":"Hofbauer CJ, Whelan SF, Hirschler M, Allacher P, Horling FM, Lawo JP, et al. Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans. Blood. 2015;125:1180\u20138.","journal-title":"Blood"},{"key":"3659_CR26","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1111\/jth.15515","volume":"19","author":"A Bonnefoy","year":"2021","unstructured":"Bonnefoy A, Merlen C, Dub\u00e9 E, Claus-Desbonnet H, Rivard GE, St-Louis J. Predictive significance of anti-FVIII immunoglobulin patterns on bleeding phenotype and outcomes in acquired hemophilia A: results from the Quebec reference center for inhibitors. J Thromb Haemost. 2021;19:2947\u201356.","journal-title":"J Thromb Haemost"},{"key":"3659_CR27","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1073\/pnas.89.9.3795","volume":"89","author":"M Algiman","year":"1992","unstructured":"Algiman M, Dietrich G, Nydegger UE, Boieldieu D, Sultan Y, Kazatchkine MD. Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals. Proc Natl Acad Sci USA. 1992;89:3795\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3659_CR28","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/jth.13304","volume":"14","author":"S Werwitzke","year":"2016","unstructured":"Werwitzke S, Geisen U, Nowak-G\u00f6ttl U, Eichler H, Stephan B, Scholz U, et al. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01\/2010 study. J Thromb Haemost. 2016;14:940\u20137.","journal-title":"J Thromb Haemost"},{"key":"3659_CR29","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1007\/s00277-022-04972-y","volume":"101","author":"A Chansavang","year":"2022","unstructured":"Chansavang A, Philippe A, Bozinovic I, Ben Hadj Ali K, Smadja D, Helley D, et al. Usefulness of anti-factor VIII IgG ELISA in acquired hemophilia A follow-up. Ann Hematol. 2022;101:2453\u201360.","journal-title":"Ann Hematol"},{"key":"3659_CR30","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ajh.23723","volume":"89","author":"KA Moser","year":"2014","unstructured":"Moser KA, Adcock Funk DM. Chromogenic factor VIII activity assay. Am J Hematol. 2014;89:781\u20134.","journal-title":"Am J Hematol"},{"key":"3659_CR31","first-page":"271","volume":"87","author":"AN Blanco","year":"2002","unstructured":"Blanco AN, Alcira Peirano A, Grosso SH, Gennari LC, P\u00e9rez Bianco R, Lazzari MA. A chromogenic substrate method for detecting and titrating anti-factor VIII antibodies in the presence of lupus anticoagulant. Haematologica. 2002;87:271\u20138.","journal-title":"Haematologica"},{"key":"3659_CR32","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12185-016-2108-x","volume":"105","author":"T Matsumoto","year":"2017","unstructured":"Matsumoto T, Nogami K, Shima M. A combined approach using global coagulation assays quickly differentiates coagulation disorders with prolonged aPTT and low levels of FVIII activity. Int J Hematol. 2017;105:174\u201383.","journal-title":"Int J Hematol"},{"key":"3659_CR33","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1055\/s-0040-1721776","volume":"121","author":"N Shimonishi","year":"2021","unstructured":"Shimonishi N, Ogiwara K, Oda Y, Kawabe T, Emmi M, Shima M, et al. Inhibitor index in the clot waveform analysis-based mixing test differentiates among hemophilia a without and with inhibitors, and lupus anticoagulant. Thromb Haemost. 2021;121:792\u20139.","journal-title":"Thromb Haemost"},{"key":"3659_CR34","doi-asserted-by":"crossref","first-page":"107602962097881","DOI":"10.1177\/1076029620978810","volume":"26","author":"D Shimomura","year":"2020","unstructured":"Shimomura D, Matsumoto T, Sugimoto K, Takata T, Kouno A, Shimada M, et al. The first-derivative curve of the coagulation waveform reveals the cause of aPTT prolongation. Clin Appl Thromb Hemost. 2020;26:1076029620978810.","journal-title":"Clin Appl Thromb Hemost"},{"key":"3659_CR35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.thromres.2023.01.007","volume":"222","author":"T Yamaguchi","year":"2023","unstructured":"Yamaguchi T, Shinozawa K, Nagatoishi S, Mitsuhashi A, Bingo M, Inaba H, et al. In vitro validation of chromogenic substrate assay for evaluation of surrogate FVIII-activity of emicizumab. Thromb Res. 2023;222:131\u20139.","journal-title":"Thromb Res"},{"key":"3659_CR36","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s11239-021-02591-4","volume":"53","author":"JW Jacobs","year":"2022","unstructured":"Jacobs JW, Gisriel SD, Iyer K, Rinder HM. Concomitant factor VIII inhibitor and lupus anticoagulant in an asymptomatic patient. J Thromb Thrombolysis. 2022;53:945\u20139.","journal-title":"J Thromb Thrombolysis"},{"key":"3659_CR37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1365-2516.2000.00372.x","volume":"6","author":"R Saxena","year":"2000","unstructured":"Saxena R, Mishra DK, Kashyap R, Choudhry VP, Mahapatra M, Bhargava M. Acquired haemophilia - a study of ten cases. Haemophilia. 2000;6:78\u201383.","journal-title":"Haemophilia"},{"key":"3659_CR38","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1067\/mva.2002.127336","volume":"36","author":"HA Brings","year":"2002","unstructured":"Brings HA, Waas JK, McCrae KR, Baele HR, Goldstone J. Successful management of life-threatening hemorrhage in a patient with synchronous lupus anticoagulant and factor VIII inhibitor. J Vasc Surg. 2002;36:853\u20135.","journal-title":"J Vasc Surg"},{"key":"3659_CR39","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1191\/0961203303lu463cr","volume":"12","author":"A Taher","year":"2003","unstructured":"Taher A, Abiad R, Uthman I. Coexistence of lupus anticoagulant and acquired haemophilia in a patient with monoclonal gammopathy of unknown significance. Lupus. 2003;12:854\u20136.","journal-title":"Lupus"},{"key":"3659_CR40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/bjh.14148","volume":"174","author":"K Nogami","year":"2016","unstructured":"Nogami K. The utility of thromboelastography in inherited and acquired bleeding disorders. Br J Haematol. 2016;174:503\u201314.","journal-title":"Br J Haematol"},{"key":"3659_CR41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5482\/HAMO-14-08-0033","volume":"35","author":"T Schneider","year":"2015","unstructured":"Schneider T, Siegemund T, Siegemund R, Petros S. Thrombin generation and rotational thromboelastometry in the healthy adult population. Hamostaseologie. 2015;35:181\u20136.","journal-title":"Hamostaseologie"},{"key":"3659_CR42","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12876-020-01413-w","volume":"20","author":"J See\u00dfle","year":"2020","unstructured":"See\u00dfle J, L\u00f6hr J, Kirchner M, Michaelis J, Merle U. Rotational thrombelastometry (ROTEM) improves hemostasis assessment compared to conventional coagulation test in ACLF and Non-ACLF patients. BMC Gastroenterol. 2020;20:271.","journal-title":"BMC Gastroenterol"},{"key":"3659_CR43","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.7754\/Clin.Lab.2016.160328","volume":"62","author":"M Durila","year":"2016","unstructured":"Durila M, Sevcikova S, Vymazal T. Stability of non-activated rotational thromboelastometry assay in time of citrated blood (appropriate time interval for analysis). Clin Lab. 2016;62:2145\u20138.","journal-title":"Clin Lab"},{"key":"3659_CR44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12185-019-02782-z","volume":"111","author":"Y Nakajima","year":"2020","unstructured":"Nakajima Y, Nogami K, Yada K, Kawamura T, Ogiwara K, Furukawa S, et al. Evaluation of clinical severity in patients with type 2N von Willebrand disease using microchip-based flow-chamber system. Int J Hematol. 2020;111:369\u201377.","journal-title":"Int J Hematol"},{"key":"3659_CR45","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.thromres.2015.05.026","volume":"136","author":"MI Meesters","year":"2015","unstructured":"Meesters MI, Koch A, Kuiper G, Zacharowski K, Boer C. Instability of the non-activated rotational thromboelastometry assay (NATEM) in citrate stored blood. Thromb Res. 2015;136:481\u20133.","journal-title":"Thromb Res"},{"key":"3659_CR46","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/00365513.2017.1394487","volume":"77","author":"P Jilma-Stohlawetz","year":"2017","unstructured":"Jilma-Stohlawetz P, Fritsche-Polanz S, Quehenberger P, Sch\u00f6rgenhofer C, Bartko J, Ristl R, et al. Evaluation of between-, within- and day-to-day variation of coagulation measured by rotational thrombelastometry (ROTEM). Scand J Clin Lab Invest. 2017;77:651\u20137.","journal-title":"Scand J Clin Lab Invest"},{"key":"3659_CR47","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1373\/clinchem.2003.028704","volume":"50","author":"J Philipp\u00e9","year":"2004","unstructured":"Philipp\u00e9 J, De Logi E, Baele G. Comparison of five different citrated tubes and their in vitro effects on platelet activation. Clin Chem. 2004;50:656\u20138.","journal-title":"Clin Chem"},{"key":"3659_CR48","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-0038-1653806","volume":"73","author":"DA Gorog","year":"1995","unstructured":"Gorog DA, Kovacs IB. Thrombotic status analyser Measurement of platelet-rich thrombus formation and lysis in native blood. Thromb Haemost. 1995;73:514\u201320.","journal-title":"Thromb Haemost"},{"key":"3659_CR49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/00001721-200301000-00007","volume":"14","author":"J Yamamoto","year":"2003","unstructured":"Yamamoto J, Yamashita T, Ikarugi H, Taka T, Hashimoto M, Ishii H, et al. G\u00f6r\u00f6g thrombosis test: a global in-vitro test of platelet function and thrombolysis. Blood Coagul Fibrinolysis. 2003;14:31\u20139.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"3659_CR50","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/01.mbc.0000169225.31173.19","volume":"16","author":"T Lang","year":"2005","unstructured":"Lang T, Bauters A, Braun SL, P\u00f6tzsch B, von Pape KW, Kolde HJ, et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis. 2005;16:301\u201310.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"3659_CR51","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/ijlh.12852","volume":"40","author":"L Hensch","year":"2018","unstructured":"Hensch L, Kostousov V, Bruzdoski K, Losos M, Pereira M, de Guzman M, et al. Does rotational thromboelastometry accurately predict coagulation status in patients with lupus anticoagulant? Int J Lab Hematol. 2018;40:521\u20136.","journal-title":"Int J Lab Hematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03659-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-023-03659-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-023-03659-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T15:28:06Z","timestamp":1698679686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-023-03659-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,26]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["3659"],"URL":"https:\/\/doi.org\/10.1007\/s12185-023-03659-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,26]]},"assertion":[{"value":"10 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"YC has received honoraria from Chugai Pharmaceuticals, Sanofi Genzyme, Bayer, Takeda Pharmaceutical, Novo Nordisk Pharma, Pfizer, KM Biologics, Japan Blood Products Organization, Fujimoto Pharmaceuticals and CSL-Behring. KA has received research grants from KM Biologics and also honoraria from Chugai Pharmaceuticals, Sanofi Genzyme, Bayer, Takeda Pharmaceutical, Novo Nordisk Pharma, Pfizer, KM Biologics, Japan Blood Products Organization and CSL-Behring. KS was an endowed Assistant Professor funded by Baxter\/Baxalta\/Shire and CSL-Behring until March 2020. MB has received funding for research as a Principle Investigator from Chugai Pharmaceuticals, and also honoraria from Chugai Pharmaceuticals, Sanofi Genzyme, Bayer, Takeda Pharmaceutical, Novo Nordisk Pharma, Pfizer, KM Biologics, and CSL-Behring. RM has received honoraria from Chugai Pharmaceutical, Sanofi, Bayer, Takeda Pharmaceutical and CSL-Behring. TY has received honoraria from Chugai Pharmaceuticals, Novo Nordisk Pharma, Bayer, Kyowa Hakko Kirin and Sanofi Genzyme. AM is the holder of an endowed chair at the Department of Gene Research of Coagulation Disorders at Tokyo Medical University, which received funding from CSL-Behring. HI has received speaker honoraria from Sanofi and CSL-Behring. TH has received research grant from Sanofi Genzyme, and also honoraria from Chugai Pharmaceuticals, Sanofi Genzyme, Bayer, Takeda Pharmaceutical, Novo Nordisk Pharma, Pfizer, KM Biologics, Japan Blood Products Organization and CSL-Behring. EK has received research grants from Chugai Pharmaceuticals and CSL-Behring, and also received honoraria from Chugai Pharmaceuticals, Sanofi Genzyme, Bayer, Takeda Pharmaceutical, Novo Nordisk Pharma, and CSL-Behring.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}